Marker Therapeutics Inc (MRKR)

Precedente Chiudi:

$4.20

Aprire:

$4.33

Volume 24 ore:

13,139

Capitalizzazione di mercato:

$37.57M

Reddito:

-

Utile/perdita netta:

$-8.24M

Rapporto P/E:

-2.7051

EPS:

-1.56

Flusso di cassa netto:

$-16.44M

1 W Prestazione:

-1.63%

1M Prestazione:

-7.25%

6M Prestazione:

+34.39%

1 anno Prestazione:

+210.29%

Intervallo 1D:

$4.15

$4.4999

Portata 52W:

$1.16

$9.6799

Marker Therapeutics Inc Stock (MRKR) Company Profile

Nome

Marker Therapeutics Inc

Settore

Healthcare (1213)

Industria

Biotechnology (699)

Telefono

713 400 6400

Indirizzo

3200 Southwest Freeway, Suite 2500, Houston, TX

Dipendente

56

Cinguettio

@MRKRTherapeutic

Prossima data di guadagno

2024-05-13

Ultimi documenti SEC

MRKR's Discussions on Twitter

Marker Therapeutics Inc Stock (MRKR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2021-03-25	Iniziato	Piper Sandler	Overweight
2021-03-19	Iniziato	Cantor Fitzgerald	Overweight
2020-05-12	Downgrade	Piper Sandler	Overweight → Neutral
2019-05-30	Iniziato	ROTH Capital	Buy
2019-03-01	Iniziato	Janney	Buy
2018-12-03	Aggiornamento	Piper Jaffray	Neutral → Overweight

Mostra tutto

Marker Therapeutics Inc Borsa (MRKR) Ultime notizie

Principal Investigator from City of Hope National Medical Center Invited to Present Clinical Data from Marker Therapeutics APOLLO Study at 11th Global Summit on Hematologic Malignancies 

GlobeNewswire Inc.

Marker Therapeutics Reports Year-End 2023 Corporate and Financial Results

GlobeNewswire Inc.

Marker Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference

GlobeNewswire Inc.

Marker Therapeutics Receives Approval from United States Adopted Name (USAN) Council and International Nonproprietary Names (INN) Expert Committee for “Neldaleucel” as Nonproprietary Name for MT-601

GlobeNewswire Inc.

Marker Therapeutics Announces Clinical Program Updates and Pipeline Prioritization

GlobeNewswire Inc.

Marker Therapeutics Announces Participation in Biotech Showcase and the 19th Annual Non-Dilutive Funding Summit During “J.P. Morgan Week 2024”

GlobeNewswire Inc.

Marker Therapeutics Inc Azioni (MRKR) Dati Finanziari

Marker Therapeutics Inc (MRKR) Reddito netto 2024

Marker Therapeutics Inc (MRKR) Flusso di cassa 2024

Marker Therapeutics Inc (MRKR) Utile per azione 2024